Depomed (DEPO)

[surf1944]

4 Biotech Stocks With Strong Cash Flow Growth Over the Last 5 Years

4. DepoMed Inc. (DEPO): Drug Manufacturers Industry. Market cap of $469.08M. TTM Operating cash flow/common equity at 1.26 vs. 3-year average at 0.52 and 5-year average at -0.20. The stock is a short squeeze candidate, with a short float at 11.89% (equivalent to 7.43 days of average volume). The stock has had a couple of great days, gaining 6.85% over the last week.

*Operating cash flow/common equity sourced from Screener.co, all other data sourced from Finviz.

http://seekingalpha.com/article/278996-4-biotech-stocks-with-strong-cash-flow-growth-over-the-last-5-years?source=yahoo